Possible effects of blood copper on hematological parameters in elderly;Possíveis efeitos do cobre sanguíneo sobre parâmetros hematológicos em idosas

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 46, Issue 6, 2010, Pages 463-470

  Baierle, Marília ^a   Valentini, Juliana ^b   Paniz, Clóvis ^c   Moro, Angela ^a   Barbosa Jr , Fernando ^b   Garcia, Solange Cristina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Universitario de Santa Maria   (Brazil)

Author keywords

ALA D activity; Copper; Elderly; Hematological parameters; ICP MS; Oxidative stress

Indexed keywords

EID: 79251495425     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/s1676-24442010000600006     Document Type: Article

References (49)

1. ALLAIN, P.; PREMEL-CABIC, A. Influence of metals and non-steroid anti-inflammatory drugs on the activity of human red cell ALA dehydratase "in vitro". Pathol Biol, v. 25, n. 8, p. 535-40, 1977.
2. ALVES, C.; LIMA, R. V. B. Dietary supplement use by adolescents. J Pediatr, v. 85, n. 4, p. 287-94, 2009.
3. ARAYA, M. et al. Supplementing copper at the upper level of the adult dietary recommended intake induces detectable but transient changes in healthy adults. J Nutr, v. 135, p. 2367-71, 2005.
4. BALKEMA, S. et al. Haemolytic anaemia as a first sign of Wilson's disease. J Med, v. 66, n. 8, p. 344-7, 2008.
5. BELBRAOUET, S. et al. Serum zinc and copper status in hospitalized vs. healthy elderly subjects. J Am Coll Nutr, v. 26, n. 6, p. 650-4, 2007.
6. BHATTACHARYA, J. et al. Interaction of hemoglobin and copper nanoparticles: implications in hemoglobinopathy. Nanomedicine, v. 2, p. 191-9, 2006.
7. BREWER, G. J. Risks of Copper and iron toxicity during aging in humans. Che Res Toxicol, v. 23, p. 319-26, 2010.
8. BREWER, G. J. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimers disease. J Am Coll Nutr, v. 28, n. 3, p. 238-42, 2009.
9. BREWER, G. J. The risks of free copper in the body and the development of useful anticopper drugs. Curr Opin Clin Nutr Metab Care, v. 11, p. 727-32, 2008.
10. BURTIS, C. A.; ASHWOOD, E. R. Fundamentos de química clínica. Rio de Janeiro: Guanabara Koogan, 1998.
11. CASHMAN, K. D. et al. No effect of copper upplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Eur J Clin Nutr, v. 55, p. 525-31, 2001.
12. DESPAUX, N. et al. Postulated mode of action of metals on purified human ALA-dehydratase. Biomedicine, v. 27, p. 358-61, 1977.
13. FAILACE, R. Hemograma. Manual de interpretação. Porto Alegre: Artmed Editora, 2003.
14. GONÇALVES, T. L. et al. Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem, v. 38, p. 1071-5, 2005.
15. GYBINA, A. A.; TKAC, I.; PROHASKA, J. R. Copper deficiency alters the neurochemical profile of developingrat brain. Nutr Neurosci, v. 12, n. 3, p. 114-22, 2009.
16. HALFDANARSON, T. R. et al. Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol, v. 80, p. 523-31, 2008.
17. HERKLOTZ, R.; RISCH, L.; HUBER, A. R. Conventional and new laboratory parameters in the evaluation of hematologic disease. Ther Umsch, v. 61, n. 2, p. 93-102, 2004.
18. HERNANDEZ, A. F. et al. Changes in erythrocyte enzymes in humans long-term exposed to pesticides Influence of several markers of individual susceptibility. Toxicol Lett, v. 159, p. 13-21, 2005.
19. HIGUCHI, T. et al. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med, p. 271-3, 2006.
20. KEDZIERSKA, K. et al. Trace elements modify the activity of sodium transporting systems in erythrocyte membrane in patients with essential hypertension-preliminary study. Nephrol Dial Transplant, v. 20, p. 469-71, 2005.
21. KLAASSEN, C. D. Casarett and Doul's toxicology: the basic science of poisons. New York: McGraw-Hill, 2001.
22. MARIANI, E. et al. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci, v. 827, p. 65-75, 2005.
23. MELGAARD, B.; CLAUSEN, J.; RASTOGI, S. C. Heavy metal levels and delta-amino-levulinic acid dehydrase levels in peripheral polyneuropathy. Acta Neurol Scand, v. 53, n. 4, p. 291-307, 1976.
24. MENÉNDEZ, A. M. et al. Relación entre las cantidades de cobre y zinc administradas a pacientes graves con nutrición parenteral total y los niveles de cobre y zinc en plasma y eritrocitos. Nutr Hosp, v. 23, n. 4, p. 373-82, 2008.
25. MEYDANI, M. Antioxidants e cognitive function. Nutr Rev, v. 59, n. 8, 75S-80S, 2001.
26. MEZZETTI, A. et al. Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Radic Biol Med, v. 25, n. 6, p. 676-81, 1998.
27. MILNE, D. B.; JOHNSON, P. E. Assessment of copper status: effect of age and gender on reference ranges in healthy adults. Clin Chem, v. 39, n. 5, p. 883-7, 1993.
28. MILNE, D. B.; NIELSEN, F. H. Effects of a diet low in copper on copper-status indicators in postmenopausal women. Am J Clin Nutr, v. 63, p. 358-64, 1996.
29. MOREIRA, F. R.; MOREIRA, J. C. A importância da análise de especiação do chumbo em plasma para a avaliação dos riscos à saúde. Quim Nova, v. 27, n. 2, p. 251-60, 2004.
30. MORO, A. M. et al. Quantificação laboratorial de cobre sérico por espectrofotometria Vis comparável à espectrometria de absorção atômica com chama. J Bras Patol Med Lab, v. 43, n. 4, p. 251-6, 2007.
31. MORRIS, M. C. et al. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol, v. 63, p. 1085-8, 2006.
32. NAGANO, T. et al. Clinical features of hematological disorders caused by copper deficiency during longterm enteral nutrition. Intern Med, v. 44, n. 6, p. 554-9, 2005.
33. PALMER, C. D. et al. Determination of lead, cadmium and mercury in blood for assessment of environmental exposure: a comparison between inductively coupled plasma-mass spectrometry and atomic absorption spectrometry. Spectrochim Acta Part B At Spectrosc, v. 61, p. 980-90, 2006.
34. PANIZ, C. Avaliação do estado micronutricional e de estresse oxidativo em idosos. Santa Maria, 2007. Dissertação de mestrado - Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria.
35. RODRIGUES, A. L.; BELLINASO, M. L.; DICK, T. Effect of some metal ions on blood and liver delta-aminolevulinate dehydratase of Pimelodus maculatus (Pisces, Pimelodidae). Comp Biochem Physiol B, v. 94, n. 1, p. 65-9, 1989.
36. SASSA, S. δ-Aminolevulinic acid dehydratase assay. Enzyme, v. 28, p. 133-45, 1982.
37. SERRA, J. A. et al. Systemic oxidative stress associated with the neurological diseases of aging. Neurochem Res, v. 34, p. 2122-32, 2009.
38. SFAR, S. et al. Zinc, copper and antioxidant enzyme activities in healthy elderly Tunisian subjects. Exp Gerontol, v. 44, p. 812-17, 2009.
39. SOUZA, J. B. et al. Delta-aminolevulinate dehydratase (δ-ALA-D) activity in diabetes and hypothyroidism. Clin Biochem, v. 40, p. 321-5, 2007.
40. SQUITTI, R. et al. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease. Prion, v. 2, n. 1, p. 23-7, 2008.
41. SUKALSKI, K. A.; LABERGE, T. P.; JOHNSON, W. T. In vivo oxidative modification of erythrocyte membrane proteins in copper deficiency. Free Radic Biol Med, v. 22, n. 5, p. 835-42, 1997.
42. THOMPSON, J.; JONES, D. D.; BEASLEY, W. H. The effect of metal ions on the activity of δ-aminolevulinic acid dehydratase. Br J Ind Med, v. 34, p. 32-6, 1977.
43. TOMOKUNI, K. The in vitro effect of metal ions on the activity of erythrocyte delta-aminolevulinic acid dehydratase. Sangyo Igaku, v. 21, n. 3, p. 240-5, 1979. (Pubitemid 10223652)
44. VALENTINI, J. et al. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomedicine & Pharmacotherapy, v. 62, p. 378-82, 2008.
45. VALENTINI, J. et al. Human erythrocyte δ-aminolevulinate dehydratase activity and oxidative stress in hemodialysis patients. Clinical Biochemistry, v. 40, p. 591-4, 2007.
46. VALKO, M.; MORRIS, H.; CRONIN, M. T. D. Metals, toxicity and oxidative stress. Curr Med Chem, v. 12, n. 10, p. 1161-208, 2005.
47. WILLIAMS, M. D. D. M. Racial differences of hemoglobin concentration: measurements of iron, copper, and zinc. Am J Clin Nutr, v. 34, p. 1694-700, 1981.
48. WORLD POPULATION PROSPECTS. The 2008 Revision Population Database. UN home. Disponível em: 〈http://esa.un.org/unpp/index.asp?panel= 2〉. Acesso em: 10 jun. 2010.
49. WU, J.; RICKER, M.; MUENCH, J. Copper deficiency as cause of unexplained hematologic and neurologic deficits in patient with prior gastrointestinal surgery. J Am Board Fam Med, v. 19, p. 191-4, 2006.